DUPILUMAB IMPROVES HISTOLOGICAL AND ENDOSCOPIC FEATURES OF EOSINOPHILIC OESOPHAGITIS IN CHILDREN AGED 1–11 YEARS IN THE PHASE 3 EOE KIDS TRIAL

Mirna Chehade  ¹     Evan S. Dellon  ²     Jonathan Spergel  ³     Marc E. Rothenberg  ⁴     Ruiqi Liu  ⁵     Leda Mannent  ⁶     Elizabeth Laws  ⁷     Eric Mortensen     Jennifer Maloney     Eilish McCann     Faisal A. Khokar     Bethany Beazley     Lila Glotfelty     Arsalan Shabbir    
¹ Icahn School of Medicine at Mount Sinai, New York, United States
² University of North Carolina School of Medicine, Chapel Hill, NC, United States
³ Children's Hospital of Philadelphia, Philadelphia, United States
⁴ Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, United States
⁵ Regeneron Pharmaceuticals, Inc., Tarrytown, United States
⁶ Sanofi, Chilly-Mazarin, France
⁷ Sanofi, Bridgewater, United States

Session
Late breaking abstracts III

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)